FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND: Form 990, tax year 2020
View the entire original 990 at ProPublica ↗
- Organization
- FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS FIND (EIN 98-0407553)
- Tax period
- 2020-01-01 to 2020-12-31
- Filed
- 2021-11-15
- IRS object ID
- 202113199349315546
- Schema version
- 2020v4.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-11-15T12:06:57-06:00 | ReturnTs |
| Tax Period End | 2020-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST & YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 99 WOOD AVENUE SOUTH | AddressLine1Txt |
| City | ISELIN | CityNm |
| State Abbreviation | NJ | StateAbbreviationCd |
| ZIP | 08830 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2020-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 980407553 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Foundation for Innovative New Diagnostics | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % LOUISA CHAUBERT DIR OF FINAN | InCareOfNm |
| Business Name Control | FOUN | BusinessNameControlTxt |
| Phone | 0000000000 | PhoneNum |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | Chemin des Mines 9 | AddressLine1Txt |
| City | GENEVA | CityNm |
| Country | SZ | CountryCd |
| Foreign Postal | 1202 | ForeignPostalCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LOUISA CHAUBERT | PersonNm |
| Person Title | DIRECTOR OF FINANCE | PersonTitleTxt |
| Phone | 0000000000 | PhoneNum |
| Signature | 2021-11-10 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | LOUISA | PersonFirstNm |
| Person Last | CHAUBERT | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | MICHAEL R SALES | PreparerPersonNm |
| PTIN | P01770943 | PTIN |
| Phone | 7325164200 | PhoneNum |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 3 | TrustedCustomerCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2020 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FIND | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | LOUISA CHAUBERT | PrincipalOfficerNm |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | Chemin des Mines 9 | AddressLine1Txt |
| City | GENEVA | CityNm |
| Country | SZ | CountryCd |
| Foreign Postal | 1202 | ForeignPostalCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $98,212,578 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.finddx.org | WebsiteAddressTxt |
| Type Of Organization Assoc | Yes (X) | TypeOfOrganizationAssocInd |
| Formation | 2003 | FormationYr |
| Legal Domicile Country | SZ | LegalDomicileCountryCd |
| Activity Or Mission | The development and implementation of new, low cost diagnostics for infectious diseases for use in low- resource areas. | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 11 | VotingMembersIndependentCnt |
| Total Employee | 142 | TotalEmployeeCnt |
| Total Volunteers | 4 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $55,842,142 | PYContributionsGrantsAmt |
| CY Contributions Grants | $97,561,319 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $314,122 | PYInvestmentIncomeAmt |
| CY Investment Income | $189,810 | CYInvestmentIncomeAmt |
| PY Other Revenue | $585,117 | PYOtherRevenueAmt |
| CY Other Revenue | $461,449 | CYOtherRevenueAmt |
| PY Total Revenue | $56,741,381 | PYTotalRevenueAmt |
| CY Total Revenue | $98,212,578 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $19,509,593 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $47,562,253 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $12,083,872 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $14,824,765 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $24,673,017 | PYOtherExpensesAmt |
| CY Other Expenses | $28,737,822 | CYOtherExpensesAmt |
| PY Total Expenses | $56,266,482 | PYTotalExpensesAmt |
| CY Total Expenses | $91,124,840 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $474,899 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $7,087,738 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $50,956,898 | TotalAssetsBOYAmt |
| Total Assets EOY | $107,298,970 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $45,058,424 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $94,312,758 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $5,898,474 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $12,986,212 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | FIND is an international non-profit organization that enables the development and delivery of much-needed diagnostic tests for poverty-related diseases. FIND acts as a bridge between experts in technology development, policy and clinical care, reducing barriers to innovation and effective implementation of diagnostic solutions in low-and-middle-income countries. | MissionDesc |
| Significant New Program Srvc | Yes (true) | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $33,608,830 | ExpenseAmt |
| Grant | $23,793,973 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | Covid-19: FIND is co-convening the diagnostics arm of the ACT Accelerator - a global collaboration to accelerate access to COVID-19 tests, treatments, and vaccines for Low Middle Income Countries (LMICs) - with the Global Fund. The aim is to ensure that everyone who needs a test can get one. FIND-specific COVID-19 activities and outputs for 2020 included: i) Comparative evaluation studies of new products that provided supplier-independent, standardized data on 80 SARS-CoV-2 diagnostics. This data is publicly available, enabling end-users to make data-driven decisions; ii) R&D and manufacturing scale-up projects for antigen-based rapid diagnostics tests (Ag RDTs), resulted in volume and price commitments for optimized tests (more robust, nasal, or oral samples), with manufacturing in India and South Africa, and support to a social enterprise model for expanded manufacturing in Senegal and Pakistan; iii) building capacity for COVID-19 diagnosis through training and enabling healthcare workers to obtain the most up-to-date information on COVID-19 testing, with ~25,000 learners enrolled in public and private courses in >190 countries; and iv) a significant project to address bottlenecks in reagent supply for assay development, by supporting antigen production in plant models, where 40% of all proteins are for use in assays for LMICs. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $10,920,188 | ExpenseAmt |
| Grant | $6,753,938 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | AMR/OUT: This program has two arms, one with a general remit of pandemic preparedness, and the other specific to the antimicrobial resistance pandemic. Outbreak focus was shifted to Covid-19, so AMR had the higher spend across two workstreams: 1) One Health digital surveillance where two pilot initiatives based on open-source digital technologies were completed in Zambia and Senegal. These systems have provided baseline data and tools for One Health analytics on WHO Glass priority pathogens as well as a broad spectrum of isolates. 2) New diagnostics that will improve gonorrhea management in LMICs to enable stewardship of new antibiotics (under development by GARDP), where the most promising reagents coming out of feasibility assessments were transferred to development of a lateral flow test to meet WHO target product profiles. The largest "outbreaks" project for 2020 aims improve preparedness and response to Lassa fever through R&D and capacity-building activities, the latter with Nigeria as a model that can be replicated in other affected regions. R&D work is still in feasibility phase, a complex project that targets a semi-open platform i.e. where different assay manufacturers can develop reagents that will run off a single device. This model can then be applied beyond Lassa fever. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $9,239,975 | ExpenseAmt |
| Grant | $5,098,221 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | TB: The two major focus areas for the TB programmes for 2020 were on i) point of care (POC) tests for TB detection, where the work was mostly R&D; ii) tests for detecting drug-resistant forms of TB (DR-TB), where the work was mostly evidence generation, both through clinical evaluations and usability and acceptability studies and cost-effectiveness analyses. The R&D work is mostly around LAM-based rapid tests, with or without a reader, and around looking at sample collection and concentration technologies and methods that may in future have applicability outside of TB as well. The DR-TB work is by far the largest part of the portfolio with technologies ranging from decentralized fully automated molecular tests for multi- and extensively drug-resistant (TB MDR and XDR- TB) to centralized molecular platforms and next-generation sequencing. The outcome of 2020 work on DR-TB was that two products received regulatory clearance (CE Mark) and evidence from FIND-led studies was provided toward four WHO recommendations. Important amongst these WHO recommendations was one for a line probe assay for pyrazinamide (PZA), which is the only LPA available for PZA - now a key drug for TB - and the only molecular test for PZA reviewed by WHO. The alternative test option (phenotypic DST) is slow, expensive, and requires BSL3. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $30,987,959 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $11,916,121 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $0 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $84,756,952 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | Yes (true) | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 0 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 142 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | IN | ForeignCountryCd |
| Foreign Country | SF | ForeignCountryCd |
| Foreign Country | VM | ForeignCountryCd |
| Foreign Country | UG | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 11 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | false | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LOUISA CHAUBERT DIR OF FINAN | PersonNm |
| Phone | 0000000000 | PhoneNum |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9 chemin des mines | AddressLine1Txt |
| City | geneva | CityNm |
| Country | SZ | CountryCd |
| Foreign Postal | 1202 | ForeignPostalCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|---|---|
| CATHARINA BOEHME | |||||||||
| CHIEF EXECUTIVE OFFICER | 40.0 | 0.0 | Yes (X) | $404,938 | $0 | $70,142 | |||
| RANGARAJAN SAMPATH | |||||||||
| CHIEF SCIENTIFIC OFFICER | 40.0 | 0.0 | Yes (X) | $322,260 | $0 | $82,621 | |||
| SERGIO CARMONA | |||||||||
| CHIEF ACCESS OFFICER | 40.0 | 0.0 | Yes (X) | $260,711 | $0 | $60,121 | |||
| LOUISA CHAUBERT | |||||||||
| DIRECTOR OF FINANCE | 40.0 | 0.0 | Yes (X) | $246,180 | $0 | $54,489 | |||
| SHARON SAACKS | |||||||||
| DIRECTOR OF OPERATIONS | 40.0 | 0.0 | Yes (X) | $211,938 | $0 | $54,539 | |||
| MORTEN RUHWALD | |||||||||
| HEAD OF TUBERCULOSIS | 40.0 | 0.0 | $201,179 | $0 | $49,981 | Yes (X) | |||
| CASSANDRA KELLY | |||||||||
| DIR. OF EMERGING THREAT | 40.0 | 0.0 | $198,078 | $0 | $46,340 | Yes (X) | |||
| ANITA SURESH | |||||||||
| HEAD OF SEQUENCING | 40.0 | 0.0 | $198,377 | $0 | $42,201 | Yes (X) | |||
| STEFANO ONGARELLO | |||||||||
| HEAD OF DATA SRVC. & BIOBANK | 40.0 | 0.0 | $196,330 | $0 | $40,343 | Yes (X) | |||
| SYLVAIN BIELER | |||||||||
| SENIOR PROJECT MANAGER | 40.0 | 0.0 | $196,499 | $0 | $32,460 | Yes (X) | |||
| SABINE DITTRICH | |||||||||
| HEAD OF MALARIA & FEVER | 40.0 | 0.0 | $184,762 | $0 | $39,338 | Yes (X) | |||
| BEATRICE MOUTON | |||||||||
| HEAD OF HUMAN RESOURCES | 40.0 | 0.0 | $187,232 | $0 | $33,989 | Yes (X) | |||
| ELENA IVANOVA | |||||||||
| TECH. INNOVATION LEAD | 40.0 | 0.0 | $187,255 | $0 | $27,256 | Yes (X) | |||
| SARAH-JANE LOVEDAY | |||||||||
| HEAD OF COMMUNICATIONS | 40.0 | 0.0 | $174,753 | $0 | $38,205 | Yes (X) | |||
| PAMELA NABETA | |||||||||
| SENIOR MANAGER QUAL/MED AFFAIR | 40.0 | 0.0 | $181,103 | $0 | $29,458 | Yes (X) | |||
| JOSEPH NDUNG'U | |||||||||
| HEAD NTD PROGRAM & FIND KENYA | 40.0 | 0.0 | $158,722 | $0 | $45,062 | Yes (X) | |||
| SONJELLE SHILTON | |||||||||
| HEPATITIS LEAD | 40.0 | 0.0 | $173,281 | $0 | $26,080 | Yes (X) | |||
| HIEDI ALBERT | |||||||||
| HEAD OF SOUTH AFRICA FIND | 40.0 | 0.0 | $181,866 | $0 | $1,270 | Yes (X) | |||
| JON BASTOW | |||||||||
| DIR. OF BUSINESS DEV. & RESOUR | 40.0 | 0.0 | Yes (X) | $83,490 | $0 | $3,727 | |||
| ZACHARY BENJAMIN KATZ | |||||||||
| CHIEF ACCESS OFFICER | 40.0 | 0.0 | Yes (X) | $63,716 | $0 | $13,303 | |||
| MARK KESSEL | |||||||||
| CHAIRMAN OF THE BOARD | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| DANIEL ROBERT CAMUS | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| ANDREW JOHN JACK | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| IONA KICKBUSH | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| CARLOS MOREL MEDICIS | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| MARCEL TANNER | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| SHEILA TLOU | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| MICHAEL WATSON | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| DAVID HEYMANN | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| GAO FU | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| KAMINENI SHOBANA | |||||||||
| board member | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $4,012,670 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $790,925 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 65 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|---|---|
| QUANTUMDX | ||||||||||
| LUGANO BUILDING 57 MELBOURNE ST | NEWCASTLE | 0 | UK | NE1 2JQ | PRODUCT DEV. SUPPORT | $14,643,606 | ||||
| DIAGNOSTIC CONSULTING NETWORK | ||||||||||
| CONTRACT ASSAY DEV. | $5,450,108 | 6354 CORTE DEL ABETO | CARLSBAD | CA | 92011 | |||||
| CAPE BIOLOGIX TECHNOLOGIES PTY LD | ||||||||||
| 5 SUNRISE CIRCLE | CAPETOWN | 0 | SF | 7405 | INCREASE PROD. CAP. | $3,583,427 | ||||
| TRANSNATIONAL TECHNOLOGIES INC | ||||||||||
| TEST OPTIMIZATION | $2,836,650 | 7324 AUBURNWOOD LANE | WINDERMERE | FL | 34786 | |||||
| THE BOSTON CONSULTING GROUP | ||||||||||
| LUDWIGTRASSE 21 | MUNCHEN | 0 | GM | 80539 | STRATEGY CONSULTING | $2,188,000 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 131 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $65,129,908 | GovernmentGrantsAmt |
| All Other Contributions | $32,431,411 | AllOtherContributionsAmt |
| Total Contributions | $97,561,319 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $189,810 | TotalRevenueColumnAmt |
| Exclusion | $189,810 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| COMMISSION ON TAX DEDUCTION | 900099 | $20,775 | $20,775 |
| OTHER INCOME | 900099 | $440,674 | $440,674 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $461,449 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $98,212,578 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $651,259 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,115,923 | TotalAmt |
| Program Services | $5,115,923 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $42,446,330 | TotalAmt |
| Program Services | $42,446,330 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,057,867 | TotalAmt |
| Program Services | $2,279,090 | ProgramServicesAmt |
| Management And General | $778,777 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,189,453 | TotalAmt |
| Program Services | $7,716,386 | ProgramServicesAmt |
| Management And General | $1,473,067 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,067,779 | TotalAmt |
| Program Services | $828,435 | ProgramServicesAmt |
| Management And General | $239,344 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $485,934 | TotalAmt |
| Program Services | $359,438 | ProgramServicesAmt |
| Management And General | $126,496 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,023,732 | TotalAmt |
| Program Services | $835,834 | ProgramServicesAmt |
| Management And General | $187,898 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $213,648 | TotalAmt |
| Program Services | $84,624 | ProgramServicesAmt |
| Management And General | $129,024 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $170,057 | TotalAmt |
| Program Services | $45,670 | ProgramServicesAmt |
| Management And General | $124,387 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $272,978 | TotalAmt |
| Program Services | $120,665 | ProgramServicesAmt |
| Management And General | $152,313 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $108,318 | TotalAmt |
| Program Services | $2,165 | ProgramServicesAmt |
| Management And General | $106,153 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,100,923 | TotalAmt |
| Program Services | $1,052,916 | ProgramServicesAmt |
| Management And General | $48,007 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,122,963 | TotalAmt |
| Program Services | $731,208 | ProgramServicesAmt |
| Management And General | $391,755 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $996,846 | TotalAmt |
| Program Services | $125,643 | ProgramServicesAmt |
| Management And General | $871,203 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $747,314 | TotalAmt |
| Program Services | $663,928 | ProgramServicesAmt |
| Management And General | $83,386 | ManagementAndGeneralAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $128,095 | TotalAmt |
| Program Services | $104,009 | ProgramServicesAmt |
| Management And General | $24,086 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,944 | TotalAmt |
| Management And General | $20,944 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $51,265 | TotalAmt |
| Program Services | $937 | ProgramServicesAmt |
| Management And General | $50,328 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| PROJECT CONTRACTORS | $15,373,041 | $14,422,759 | $950,282 |
| EQUIPMENT & SUPPLIES | $7,772,381 | $7,722,636 | $49,745 |
| PRINTING & PUBLICATIONS | $143,044 | $98,356 | $44,688 |
| BANK & SIMILAR CHARGES | $516,005 | $516,005 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $91,124,840 | TotalAmt |
| Program Services | $84,756,952 | ProgramServicesAmt |
| Management And General | $6,367,888 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,054 | BOYAmt |
| EOY | $846 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $40,869,754 | BOYAmt |
| EOY | $89,676,764 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,226,115 | BOYAmt |
| EOY | $3,199,569 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,573,565 | BOYAmt |
| EOY | $14,136,618 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $74,781 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $47,396 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $46,645 | BOYAmt |
| EOY | $27,385 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $238,765 | BOYAmt |
| EOY | $257,788 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $50,956,898 | BOYAmt |
| EOY | $107,298,970 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,559,213 | BOYAmt |
| EOY | $12,358,346 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $37,499,211 | BOYAmt |
| EOY | $81,954,412 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $45,058,424 | BOYAmt |
| EOY | $94,312,758 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,433,218 | BOYAmt |
| EOY | $7,724,169 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $465,256 | BOYAmt |
| EOY | $5,262,043 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,898,474 | BOYAmt |
| EOY | $12,986,212 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $50,956,898 | BOYAmt |
| EOY | $107,298,970 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $7,087,738 | ReconcilationRevenueExpnssAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $33,235,693 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $48,242,841 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $59,513,727 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $55,842,142 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $97,561,319 | CurrentTaxYearAmt |
| Total | $294,395,722 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $33,235,693 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $48,242,841 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $59,513,727 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $55,842,142 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $97,561,319 | CurrentTaxYearAmt |
| Total | $294,395,722 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $79,359,175 | SubstantialContributorsTotAmt |
| Public Support Total170 | $215,036,547 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $307,354 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $96,253 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $340,946 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $314,122 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $189,810 | CurrentTaxYearAmt |
| Total | $1,248,485 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $330,960 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $315,314 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $447,040 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $585,117 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $461,449 | CurrentTaxYearAmt |
| Total | $2,139,880 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $297,784,087 | TotalSupportAmt |
| Public Support CY170 | 0.72212 | PublicSupportCY170Pct |
| Public Support PY170 | 0.63900 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp | |
| Buildings | BuildingsGrp | |
| Leasehold Improvements | LeaseholdImprovementsGrp |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $74,781 | OtherCostOrOtherBasisAmt |
| Depreciation | $47,396 | DepreciationAmt |
| Book Value | $27,385 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Land Buildings | OtherLandBuildingsGrp | |
| Total Book Value Land Buildings | $27,385 | TotalBookValueLandBuildingsAmt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| Sub-Saharan Africa | 2 | 3 | Program Services | SEE PART V | $9,969,762 |
| South Asia | 1 | 86 | Program Services | SEE PART V | $10,651,718 |
| East Asia and the Pacific | 1 | 3 | Program Services | SEE PART V | $5,090,270 |
| Europe (Including Iceland and Greenland) | 1 | 79 | Program Services | SEE PART V | $50,497,238 |
| South America | 0 | 0 | Program Services | See Part V | $1,074,061 |
| Central America and the Caribbean | 0 | 0 | Program Services | See Part V | $2,891 |
| Russia and the Newly Independent States | 0 | 0 | Program Services | See Part V | $671,384 |
| Middle East and North Africa | 0 | 0 | Program Services | See Part V | $113,883 |
| North America | 0 | 0 | Program Services | See Part V | $1,660,279 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 5 | SubtotalOfficesCnt |
| Subtotal Employees | 171 | SubtotalEmployeesCnt |
| Total Office | 5 | TotalOfficeCnt |
| Total Employee | 171 | TotalEmployeeCnt |
| Subtotal Spent | $79,731,486 | SubtotalSpentAmt |
| Total Spent | $79,731,486 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (6 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt | Description Of Non Cash AsstDescriptionOfNonCashAsstTxt | Valuation Method UsedValuationMethodUsedDesc |
|---|---|---|---|---|---|---|
| South Asia | Reception of a research materials Sponsored research Analyze HCV RNA COVID-19 Screening and Testing To support TB elimination efforts production of LAM and Mtb Development of diagnotic tests To build a mobile app Study of Xpert MTB/XDR Clinical Development of diagnotic tests Technical Dossier review FIND AFI Study Optimization of the diagnostic network To develop assays TB diagnostics To build a mobile app obtain material for reasearch Development of diagnostic for TB Provide material for publication Consulting services Development of diagnostics Assess HCV self-testing Zika virus diagnostics test SARS-CoV2 immunoassays Storage of specimen samples | $2,005,563 | elec fd tran | $0 | N/A | N/A |
| East Asia and the Pacific | none | $3,237,936 | elec fd tran | $0 | N/A | N/A |
| Europe (Including Iceland and Greenland) | none | $26,903,697 | elec fd tran | $0 | N/A | N/A |
| North America | none | $1,506,939 | elec fd tran | $0 | N/A | N/A |
| South America | none | $921,848 | elec fd tran | $0 | N/A | N/A |
| Sub-Saharan Africa | none | $7,870,347 | elec fd tran | $0 | N/A | N/A |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 113 | Total501c3OrgCnt |
| Total Other Org | 192 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE F, PART I, LINE 2: | Contracts are given for research and development of new tools for the diagnosis of infectious diseases. Except for the initial advance payments, payments are conditional upon achievement of milestones or deliverables through the period of the contract as evidenced in contractually specified reports. In addition to the regular reports, program managers monitor progress with regular communications and physical and virtual site visits. Finally, most major grants are subject to annual donor audits which are in addition to the statutory audit. |
| Schedule F, Part I, Line 3, Column E: PROGRAM SERVICE DESCRIPTION | In each region, FIND conducted the following program services: Laboratory Strengthening Evaluation Work. Schedule F, Part I, Line 3, Column F all expenditures are reported under the accrual accounting method. |
| Schedule F, Part II, Line 2: | Due to the high volume of organizations that were provided assistance from FIND during 2020, it would be difficult for FIND to list each organization and grant amount individually on Schedule F, Part II. Therefore, FIND has listed the total amount of assistance provided for each region in 2020. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (28 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|---|---|
| Colorado State University US | ||||||||||
| 711 Oval Drive | FORT COLLINS | CO | 805232002 | 846000545 | 501 C (3) | $31,530 | $0 | N/A | n/a | |
| Diagnostic Consulting Network Inc | ||||||||||
| 6354 CORTE DEL ABERTO | CARLSBAD | CA | 92011 | $2,583,053 | $0 | N/A | N/A | |||
| Dimagi Inc | ||||||||||
| 585 MASSACHUSETTS AVE | CAMBRIDGE | MA | 02139 | $243,082 | $0 | N/A | N/A | |||
| Diabetes Technology Society (DTS) | ||||||||||
| 845 Malcom Road | Burlingame | CA | 94010 | 300012730 | 501(c)(3) | $20,250 | $0 | N/A | N/A | Consolidation of publications |
| Drugs & Diagnostics for Tropical Diseases | ||||||||||
| 4898 Ronson Ct | san diego | CA | 92111 | 274482027 | 501 C (3) | $279,900 | $0 | N/A | N/A | |
| Exponent | ||||||||||
| 1075 Worcester Street | natick | MA | 01760 | $70,000 | $0 | N/A | N/A | |||
| Johns Hopkins University | ||||||||||
| 733 N Broadway | baltimore | MD | 221051832 | 520595110 | 501 C (3) | $57,899 | $0 | N/A | N/A | |
| Llamasoft Inc | ||||||||||
| 201 S Division St | ANN ARBOR | MI | 481042259 | $157,400 | $0 | N/A | N/A | |||
| MMU | ||||||||||
| 201 S Division | ann arbor | MI | 48104 | $16,228 | $0 | N/A | N/A | assessment of molecular ID assay | ||
| Meso Scale Diagnostics LLC | ||||||||||
| 1601 Research Boulevard | rockville | MD | 20850 | $6,250 | $0 | N/A | N/A | |||
| MRIGlobal | ||||||||||
| 425 Volker Blvd | Kansas City | MO | 641102241 | 440545878 | 501(c)(3) | $25,224 | $0 | N/A | N/A | Lab testing & system assistance |
| Rutgers The State University of New Jersey | ||||||||||
| 65 Davidson Rd | piscataway | NJ | 088545602 | 226001086 | 501 C (3) | $102,300 | $0 | N/A | N/A | |
| Sachin Silva | ||||||||||
| 24 Peabody Terrace Apt 1401 | Cambridge | MA | 02138 | $37,720 | $0 | N/A | N/A | analysis of diagnostics | ||
| Scanwell Health | ||||||||||
| 800 Wilshire Blvd | los angeles | CA | 90017 | $240,268 | $0 | N/A | N/A | |||
| Serimmune Inc | ||||||||||
| 150 Castilian Drive | goleta | CA | 93117 | $6,000 | $0 | N/A | N/A | |||
| The Broad Institute Inc | ||||||||||
| 415 Main Street | cambridge | MA | 02142 | $77,500 | $0 | N/A | N/A | |||
| The Center for Affordable Health | ||||||||||
| 4938 Hampden Ln 186 | bethesda | MD | 20814 | $139,872 | $0 | N/A | N/A | |||
| The Regents of the University of california | ||||||||||
| 9500 Gilman Drive | la jolla | CA | 920630602 | 943067788 | 501 C (3) | $283,592 | $0 | N/A | N/A | |
| Treatment Action Group | ||||||||||
| 90 Broad St Suite 2503 | new york | NY | 10004 | 133624785 | 501 C (3) | $27,951 | $0 | N/A | N/A | |
| University of Washington | ||||||||||
| 4333 Brooklyn Avenue NE Box 359472 | seattle | WA | 98195 | 916001537 | 501 C (3) | $21,706 | $0 | N/A | N/A | |
| Vitalant dba Vitalant Research Institute | ||||||||||
| 270 Masonic ave | SAN FRANSCISCO | CA | 941184417 | 860098929 | 501 C (3) | $260,658 | $0 | N/A | N/A | |
| Washington University in St Louis | ||||||||||
| One Brookings Drive | ST LOUIS | MO | 63130 | 430653611 | 501 C (3) | $47,808 | $0 | N/A | N/A | |
| ZeptoMetrix | ||||||||||
| 872 Main Street | BUFFALO | NY | 14202 | $39,067 | $0 | N/A | N/A | NONE | ||
| Biomedical Research Institute | ||||||||||
| 9410 KEY WEST AVENUE | ROCKVILLE | MD | 20850 | 362229561 | 501(C)(3) | $14,556 | $0 | N/A | N/A | |
| Boston Children's Hospital | ||||||||||
| 300 LONGOOD AVE | BOSTON | MA | 02215 | 042774441 | 501(C)(3) | $32,578 | $0 | N/A | N/A | |
| Boston University | ||||||||||
| 25 BUICK ST 2ND FL | BOSTON | MA | 02215 | 042103547 | 501(C)(3) | $12,450 | $0 | N/A | N/A | |
| BroadReach Consulting LLC | ||||||||||
| 2000 M ST NW | WASHINGTON | DC | 20036 | $65,258 | $0 | N/A | N/A | |||
| CHAI -Clinton Health Access Initiation Inc | ||||||||||
| 383 DORCHESTER AVE | BOSTON | MA | 02127 | 271414646 | 501(C)(3) | $180,741 | $0 | N/A | N/A | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 15 | Total501c3OrgCnt |
| Total Other Org | 14 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | schedule f, Part I, Line 2 | FormAndLineReferenceDesc |
| Explanation | procedures for monitoring use of grant funds Contracts are given for research and development of new tools for the diagnosis of infectious diseases. Except for the initial advance payments, payments are conditional upon achievement of milestones or deliverables through the period of the contract as evidenced in contractually specified reports. In addition to the regular reports, program managers monitor progress with regular communications and site visits. Finally, most major grants are subject to annual donor audits which are in addition to the statutory audit. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (18 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CATHARINA BOEHME | ||||||||||||||
| CHIEF EXECUTIVE OFFICER | $352,251 | $0 | $52,687 | $0 | $0 | $0 | $62,505 | $0 | $7,637 | $0 | $475,080 | $0 | $0 | $0 |
| RANGARAJAN SAMPATH | ||||||||||||||
| CHIEF SCIENTIFIC OFFICER | $303,820 | $0 | $18,440 | $0 | $0 | $0 | $64,292 | $0 | $18,329 | $0 | $404,881 | $0 | $0 | $0 |
| SHARON SAACKS | ||||||||||||||
| DIRECTOR OF OPERATIONS | $203,603 | $0 | $8,335 | $0 | $0 | $0 | $44,058 | $0 | $10,481 | $0 | $266,477 | $0 | $0 | $0 |
| LOUISA CHAUBERT | ||||||||||||||
| DIRECTOR OF FINANCE | $228,846 | $0 | $17,334 | $0 | $0 | $0 | $48,125 | $0 | $6,364 | $0 | $300,669 | $0 | $0 | $0 |
| CASSANDRA KELLY | ||||||||||||||
| DIR. OF EMERGING THREAT | $184,316 | $0 | $13,762 | $0 | $0 | $0 | $36,612 | $0 | $9,728 | $0 | $244,418 | $0 | $0 | $0 |
| SERGIO CARMONA | ||||||||||||||
| CHIEF ACCESS OFFICER | $253,946 | $0 | $6,765 | $0 | $0 | $0 | $53,757 | $0 | $6,364 | $0 | $320,832 | $0 | $0 | $0 |
| BEATRICE MOUTON | ||||||||||||||
| HEAD OF HUMAN RESOURCES | $177,664 | $0 | $9,568 | $0 | $0 | $0 | $33,989 | $0 | $0 | $0 | $221,221 | $0 | $0 | $0 |
| JOSEPH NDUNG'U | ||||||||||||||
| HEAD NTD PROGRAM & FIND KENYA | $158,722 | $0 | $0 | $0 | $0 | $0 | $34,871 | $0 | $10,191 | $0 | $203,784 | $0 | $0 | $0 |
| STEFANO ONGARELLO | ||||||||||||||
| HEAD OF DATA SRVC. & BIOBANK | $185,803 | $0 | $10,527 | $0 | $0 | $0 | $31,112 | $0 | $9,231 | $0 | $236,673 | $0 | $0 | $0 |
| MORTEN RUHWALD | ||||||||||||||
| HEAD OF TUBERCULOSIS | $196,701 | $0 | $4,478 | $0 | $0 | $0 | $40,476 | $0 | $9,505 | $0 | $251,160 | $0 | $0 | $0 |
| SABINE DITTRICH | ||||||||||||||
| HEAD OF MALARIA & FEVER | $177,649 | $0 | $7,113 | $0 | $0 | $0 | $30,391 | $0 | $8,947 | $0 | $224,100 | $0 | $0 | $0 |
| SARAH-JANE LOVEDAY | ||||||||||||||
| HEAD OF COMMUNICATIONS | $164,879 | $0 | $9,874 | $0 | $0 | $0 | $29,484 | $0 | $8,721 | $0 | $212,958 | $0 | $0 | $0 |
| HIEDI ALBERT | ||||||||||||||
| HEAD OF SOUTH AFRICA FIND | $181,866 | $0 | $0 | $0 | $0 | $0 | $1,270 | $0 | $0 | $0 | $183,136 | $0 | $0 | $0 |
| ANITA SURESH | ||||||||||||||
| HEAD OF SEQUENCING | $183,888 | $0 | $14,489 | $0 | $0 | $0 | $32,726 | $0 | $9,475 | $0 | $240,578 | $0 | $0 | $0 |
| SYLVAIN BIELER | ||||||||||||||
| SENIOR PROJECT MANAGER | $196,499 | $0 | $0 | $0 | $0 | $0 | $32,460 | $0 | $0 | $0 | $228,959 | $0 | $0 | $0 |
| ELENA IVANOVA | ||||||||||||||
| TECH. INNOVATION LEAD | $173,978 | $0 | $13,277 | $0 | $0 | $0 | $27,256 | $0 | $0 | $0 | $214,511 | $0 | $0 | $0 |
| PAMELA NABETA | ||||||||||||||
| SENIOR MANAGER QUAL/MED AFFAIR | $174,580 | $0 | $6,523 | $0 | $0 | $0 | $29,458 | $0 | $0 | $0 | $210,561 | $0 | $0 | $0 |
| SONJELLE SHILTON | ||||||||||||||
| HEPATITIS LEAD | $164,746 | $0 | $8,535 | $0 | $0 | $0 | $26,080 | $0 | $0 | $0 | $199,361 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule J, Part I, Line 4a | FormAndLineReferenceDesc |
| Explanation | severance payment Jon Bastow received termination benefits during 2020 in the amount of $18,286. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, BOX E: | THE ORGANIZATION'S TELEPHONE NUMBER IS +41 (22) 710 05 90. |
| FORM 990, PART III, LINE 2: | NEW PROGRAM SERVICES In response to the Covid-19 pandemic, FIND has responded with a new program stream, Covid-19 and pandemic preparedness. The details of the program are described in Part III Line 4. |
| FORM 990, PART III, LINE 4D: | other program SERVICES program services for Access, Fever & Malaria, HCV & HIV, and Neglected Tropical Diseases. A summary of each program is given below. PROGRAM - Access: Expenses - $15,437,143 including grants $3,183,085 Program scope is broad with multiple focus areas that will ultimately enable access to testing. For India, 2020 included COVD-19 response work (testing, sequencing, reagent development). With traditional TB programs at risk, we worked to strengthen bi-directional screening. Despite COVID, TB lab work continued - Karnataka became India's first state where all three Intermediate Reference Laboratories achieved ISO accreditation. EQA methods were established in >1,100 sites, and quality TB care services extended to private sector patients (~190,000 patients notified >82% successful treatment outcomes reported in a 3-month period). We also continued to work on micro-elimination of HCV in prisons and had two community-based delivery model projects running in India. These projects (another is in Senegal) target TB and diabetes as a leading co-morbidity factor for TB patients, cater to rural communities and leverage existing networks, such as women-led community groups. Diagnostic network optimization (DNO) was carried out in Central African Republic, the Gambia, India, and Rwanda. DNO analysis that matches testing demand with testing capacity increases access, improves efficiency, and develops routing for specimen referral networks. This project was adapted to respond to COVID-19 testing demands. PROGRAM - Fever & Malaria: Expenses - $4,052,356 including grants of $2,098,277 The work for malaria targets tools to meet one of the few remaining diagnostic gaps in malaria, specifically robust tools to use in P. vivax malaria elimination. For fever, our primary focus is tools for differential diagnosis of patients who present with fever at the primary healthcare level where studies have confirmed ~90% of patients with a negative malaria test received antibiotics, fueling anti-microbial resistance. PROGRAM - HCV and HIV: Expenses - $6,442,490 including grants of $3,679,160 The work was for HCV only, and bulk of 2020 work was on 1) sampling methods that eliminate cold chain needs, critical for increasing access to testing at lower levels of the healthcare system; it also allows for integration into existing HIV DBS systems; and 2) evaluation of self-testing that includes using portable molecular diagnostics shown that this approach can help overcome apathy towards testing and mitigate barriers to clinic based testing. PROGRAM - NTDs: Expenses - $5,055,970 including grants of $2,955,599 FIND works on five different NTDs: Chagas disease, Buruli ulcer, sleeping sickness, visceral leishmaniasis and schistosomiasis. Work in each of these disease areas is shaped to address primary gaps in elimination strategies, for example for HAT, in 2020 we started shaping our ongoing R&D and large-scale country projects to be in line with changing elimination strategies and supply challenges (which is a common problem for tests for NTDs). Form 990, Part V, Line 2a and Part VII, Section A Individuals employed by the FIND are not U.S. Residents or U.S. employees. Information pertaining to the number of employees and employee compensation is provided using the best information available from equivalent W-2 and W-3 Forms for the various countries in which the FIND employs individuals. |
| FORM 990, PART VI, LINE 11B: | FORM 990 REVIEW PROCESS THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM AND REVIEWED BY THE DIRECTOR OF FINANCE. ONCE APPROVED BY THE DIRECTOR OF FINANCE, THE FORM 990 IS ALSO REVIEWED BY THE CEO. ADDITIONALLY, IN 2019 FIND PARTICIPATED IN A BENCHMARKING EXERCISE WITH PEER ORGANIZATION TO ENSURE CONSISTENCY OF TREATMENT OF VARIOUS ITEMS ON FORM 990. |
| FORM 990, PART VI, LINE 12C: | FIND's conflict of interest policy requires directors, officers and key employees, all other staff members, board members consultants and partners to disclose actual or potential conflicts of interest when they arise. The person or company is also required to recuse themselves from any decision making. |
| FORM 990, PART VI, LINES 15A & 15B: | COMPENSATION REVIEW AND APPROVAL PROCESS A review by an independent consultant of the CEO's remuneration package was done by the Board and forms the basis of written employment contract. Remuneration terms for officers and key employees are based on market rates for similar positions in specific locations. This benchmarking is done against an independent report which presents data collected for similar organizations and this exercise is done every 3 years. Salaries for all staff are available to the Board and Compensation Committee. However, the salaries of the C-suite and other key staff are approved by the Compensation Committee. |
| FORM 990, PART VI, LINES 19: | AVAILABILITY OF GOVERNING DOCUMENTS TO THE PUBLIC FIND's governing documents (Statutes and By-Laws) Conflict of Interest policy and Financial Statements are available for inspection at FIND's offices in Geneva upon request. |
| FORM 990, PART VI, LINE 20: | Books in care of phone number The telephone number of the person who possesses the books and records is: +41 (22) 710 05 90. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd | Province Or StateForeignAddress/ProvinceOrStateNm |
|---|---|---|---|---|---|---|---|---|---|---|
| FIND INDIA | ||||||||||
| FLAT NO 8 9TH FL 17 BARAKHAMBA RD | NEW DELHI | IN | 110001 | PROGRAM SVCS | IN | N/A | N/A | FIND SWISS | Yes (true) | |
| FIND DX NPC | ||||||||||
| 89 ROODEBLOEM ROAD | WOODSTOCK | SF | PROGRAM SVCS | SF | N/A | N/A | FIND SWISS | Yes (true) | CAPE TOWN | |
| FIND DX KENYA | ||||||||||
| OFF MBAGATHI RD PO BOX 54840 | NAIROBI | KE | 00200 | PROGRAM SVCS | KE | N/A | N/A | FIND SWISS | Yes (true) | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (2 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| find india | ||
| r | $1,419,044 | fmv |
| find dx npc | ||
| r | $329,400 | fmv |